3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
50
Prostatic Neoplasms
44
Multiple Myeloma
22
Neoplasm Metastasis
17
Osteoporosis
14
Pain
11
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Neoplasms, Plasma Cell
5
Lung Neoplasms
5
Bone Diseases, Metabolic
5
Fractures, Bone
4
Bone Diseases
4
Lymphoma
3
Carcinoma, Renal Cell
3
Bone Neoplasms
3
Spinal Cord Compression
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Kidney Neoplasms
2
Humoral Hypercalcemia Of Malignancy
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Renal Insufficiency
1
Recurrence
1
Pleural Effusion, Malignant
1
Interventions
Cyclophosphamide
10
Irinotecan
8
Melphalan
7
Vincristine
6
Temozolomide
6
Doxorubicin
6
Busulfan
6
Topotecan
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Ifosfamide
4
Filgrastim
4
Etoposide
4
Albumin-Bound Paclitaxel
4
Trabectedin
3
Sirolimus
3
Nivolumab
3
130-nm albumin-bound paclitaxel
3
pegfilgrastim
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
eribulin
2
cixutumumab
2
abemaciclib
2
X-Rays
2
Radiotherapy, Intensity-Modulated
2
Peripheral Blood Stem Cell Transplantation
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Ewing
×
Zoledronic Acid
×
Clear all
NCT00987636
2019-10-22
EWING2008
University Hospital Muenster
Phase 3
Completed
907 enrolled